HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.

J Cancer Res Clin Oncol · 2021 · PMC8021510 · PMID 33543328

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

showed a trendp = 0.075so close (0.05 < p ≤ 0.1)

Our study revealed HER2 CN-high patients showed a trend of intestinal-type GA predominant ( p = 0.075) and older age ( p = 0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.